U.S. Hospitality Stock News

Carpenter Technology (CRS) is back in focus as investors weigh its role in supplying specialty alloys to aerospace, defense, and industrial customers, with interest tied to themes such as re-arming and reshoring manufacturing. See our latest analysis for Carpenter Technology. After a sharp run that has drawn fresh attention to its aerospace and defense exposure, Carpenter Technology’s shares now trade at US$321.26, with a 90 day share price return of 33.25% and a 1 year total shareholder...

Arcus Biosciences recently outlined its 2026 priorities, including multiple planned data readouts for casdatifan in clear cell renal cell carcinoma and ongoing development of quemliclustat for first-line pancreatic cancer. An interesting angle for investors is how Arcus is positioning casdatifan through both early- and late-line trials as part of a "fast-to-market" approach in kidney cancer while also building an emerging inflammation and immunology franchise. Next, we’ll examine how this...

Why LGI Homes Is On Investors’ Radar Today LGI Homes (LGIH) has been drawing fresh attention as investors reassess the US homebuilder’s share performance, business mix, and recent financial metrics, including revenue, earnings, and longer term total returns. See our latest analysis for LGI Homes. After a sharp 8.4% 1 day share price return to around $46.77 and a 7 day share price return of 8.9%, LGI Homes is showing short term momentum. However, its 1 year total shareholder return of around a...

In recent days, Zillow released its latest Consumer Housing Trends Report and hottest markets forecast, highlighting that nearly three in five renters expect to keep renting in 2026 and that Hartford is projected to see the strongest home price growth with tight inventory conditions. These findings suggest that lifestyle-driven renting and concentrated demand in select markets like Hartford could reshape how households use Zillow’s platforms and services. Next, we'll examine how the rise of...

If you are wondering whether Resideo Technologies is priced attractively or already baking in high expectations, you are in the right place. The stock last closed at US$36.86, with returns of 5.0% over 7 days, 9.8% over 30 days, 4.8% year to date, 63.4% over 1 year, 98.2% over 3 years, and 44.5% over 5 years, which raises fair questions about how much value is now reflected in the share price. Recent coverage has focused on Resideo's position in residential comfort, security and energy...

If you are wondering whether Cadence Bank's current share price offers good value or not, you are in the right place because this article focuses squarely on what investors may be paying for today. Cadence Bank's stock has recently closed at US$45.67, with returns of 6.6% over 7 days, 9.7% over 30 days, 5.7% year to date, 34.3% over 1 year and 76.9% over 5 years. This raises questions about how much of this performance is already reflected in the price. Recent attention on Cadence Bank has...

If you are wondering whether Polaris is fairly priced or has room to run, you are not alone. This article will walk you through what the current valuation signals are really saying. The stock last closed at US$73.60, with returns of 16.4% over the past 7 days, 9.9% over 30 days, 10.7% year to date, 40.2% over 1 year, and longer term returns of a 23.3% decline over 3 years and a 19.6% decline over 5 years, pointing to a mixed picture for investors. Recent attention on Polaris has been shaped...

ANI Pharmaceuticals recently announced that CEO Nikhil Lalwani would present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with the session available via live and archived webcast on the company’s website for 30 days. This conference appearance comes as ANI’s rare disease portfolio, including Cortrophin Gel and acquired ophthalmology products, underpins strong recent financial performance and growing investor attention. Now we’ll examine how robust 2025 results in...

FactSet Research Systems recently filed its latest Form 10-Q, outlining its recent financial and operational performance across the Americas, EMEA, and Asia Pacific segments. The filing highlights how FactSet is weaving AI-powered tools more deeply into its platform to enhance client insights and streamline workflows worldwide. Next, we’ll explore how FactSet’s expanded AI integration within its platform could influence the company’s existing investment narrative and outlook. We've found 11...

GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing a collaboration with NXP Semiconductors focused on edge AI concepts for anesthesia delivery and neonatal monitoring, with both concepts scheduled to be showcased at CES 2026. See our latest analysis for GE HealthCare Technologies. The edge AI announcement lands after a strong run in the shares, with a 90 day share price return of 24.15% and a 1 year total shareholder return of 2.43%. This suggests that near term...

In early January 2026, OneMain Holdings announced a US$1.00 billion senior notes sale, adding to a balance sheet that already carries a debt-to-equity ratio of 6.6× and serves mainly nonprime borrowers. This move increases an already heavy reliance on leverage, raising fresh questions about how the company balances funding needs against financial flexibility and risk. Next, we’ll examine how issuing US$1.00 billion in new senior notes may reshape OneMain’s investment narrative and...

Leonardo DRS, Inc. recently appointed long-time executive Sally A. Wallace as Executive Vice President and Chief Operating Officer, succeeding new President and CEO John Baylouny as part of a broader leadership transition at the defense electronics company. This elevation of a veteran insider with deep operational and technical credentials signals continuity in execution as Leonardo DRS pursues advanced defense technology programs and international collaborations. We’ll now examine how...

If you are wondering whether Globalstar's recent share price is still good value or already stretched, the next sections will walk through what the current market price might be implying. The stock has had a choppy run, with a 2.1% decline over the last week, a 12.4% decline over the last month, a 6.6% decline year to date, a 101.2% gain over the last year, and a 174.8% return over three years. These moves sit against growing investor interest in satellite connectivity and related telecom...

Biogen (BIIB) is back in focus after Chinese regulators accepted the Biologics License Application for a subcutaneous version of LEQEMBI, highlighting a potential shift toward more convenient Alzheimer’s treatment and influencing recent sentiment around the stock. See our latest analysis for Biogen. The LEQEMBI update lands after a strong 90-day share price return of 26.90% and a 30-day share price return of 5.78%, while the 1-year total shareholder return of 23.38% contrasts with weaker 3...

In early January 2026, Marathon Petroleum drew attention after recent U.S. actions toward Venezuela raised the prospect of greater heavy-crude flows that Gulf Coast refiners, including Marathon’s large Garyville facility, are well equipped to process. Investors are now weighing how Marathon’s ability to handle additional Venezuelan heavy crude could interact with its existing refining advantages and upcoming fourth-quarter 2025 earnings announcement. Next, we’ll examine how Marathon’s...

If you are wondering whether Fresh Del Monte Produce at around US$35.66 is offering good value today, this article will walk you through how the current share price lines up against different measures of worth. The stock has had a mixed run recently, with a 0.1% move over the past week, a 3.0% decline over the last 30 days, a 1.0% gain year to date, and a 18.7% return over 1 year, extending to 42.9% over 3 years and 65.5% over 5 years. Recent attention on Fresh Del Monte Produce has focused...

Anywhere Real Estate: Recent Performance Snapshot Anywhere Real Estate (HOUS) has been catching investor attention after a sharp move in its share price, with recent returns standing at 3.6% over the past day and 24.6% across the past week. Those short term gains sit alongside a month return of 20% and an approximately 87% move over the past 3 months, putting the current share price at US$17.64 as of the latest close. See our latest analysis for Anywhere Real Estate. Looking beyond the recent...

Onto Innovation recently announced that CEO Michael Plisinski and CFO Brian Roberts participated in the 28th Annual Needham Growth Conference in New York, offering a webcast fireside chat and one‑on‑one investor meetings whose materials remain available on the company’s investor relations site. This outreach, alongside increasingly positive commentary from multiple analysts on semiconductor equipment demand and Onto Innovation’s business fundamentals, has helped sharpen investor focus on the...

Earlier this week, Bank of America Securities reaffirmed a positive analyst rating on Boston Scientific and highlighted progress in its Global Pulsed Field Ablation Trial targeting persistent atrial fibrillation. This focus on pulsed field ablation underscores how Boston Scientific is positioning its electrophysiology portfolio around minimally invasive treatments for complex cardiac rhythm disorders. We’ll now examine how upbeat analyst sentiment around electrophysiology demand and pulsed...

If you are wondering whether OSI Systems at around US$279.61 is offering fair value or stretching expectations, this breakdown is designed to help you size that up with clear numbers. The stock has posted returns of 9.6% over the last 7 days, 7.4% over the last 30 days, 9.4% year to date, 77.3% over 1 year, 224.4% over 3 years, and 194.4% over 5 years, which naturally raises questions about what is already reflected in the current price. Recent coverage has focused on OSI Systems as a...

Fresh commentary around U.S. cannabis rescheduling has put Innovative Industrial Properties (IIPR) back in focus, as investors weigh what stronger tenant credit profiles could mean for its dividend coverage and preferred share payouts. See our latest analysis for Innovative Industrial Properties. That backdrop helps explain why the stock’s recent momentum has been mixed, with a 7 day share price return of 5.28% alongside a 1 year total shareholder return of 12.52%, and deeper 3 year and 5...

IDEXX Laboratories recently prepared to release its fiscal Q4 2025 results, with analysts highlighting ongoing profit strength supported by its Companion Animal Group Diagnostics segment and growing demand for diagnostic instruments and cloud-based software. Analysts’ consistently optimistic earnings expectations and the company’s track record of surpassing profit estimates have reinforced confidence in the resilience of IDEXX’s diagnostics-led business model. Now, we’ll examine how optimism...

If you are wondering whether Morgan Stanley's share price still offers value after a strong run, this article will help you frame that question clearly. The stock recently closed at US$184.68, with returns of 4.0% over 7 days, 3.3% over 30 days, 1.5% year to date, 48.5% over 1 year, 125.8% over 3 years, and 183.3% over 5 years. Recent coverage has focused on Morgan Stanley's position as a major US diversified financials group, with attention on how global deal activity, wealth management...

PriceSmart (PSMT) has just opened its 2026 financial year with Q1 same store sales growth of 8%, coming on the heels of Q4 2025 revenue of US$1.3 billion and basic EPS of US$1.02, alongside trailing twelve month EPS of US$4.82 on revenue of US$5.3 billion. The company has seen quarterly revenue move from US$1.26 billion in Q1 2025 to US$1.36 billion in Q2, then US$1.32 billion in Q3 and US$1.33 billion in Q4, while basic EPS over that stretch ranged from US$1.21 to US$1.45. This sets up Q1...